Cargando…
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
The interaction of the host immune system with tumor cells in the tissue microenvironment is essential in understanding tumor immunity and development of successful cancer immunotherapy. The presence of lymphocytes in tumors is highly correlated with an improved outcome. T cells have a set of cell s...
Autores principales: | Barrueto, Luisa, Caminero, Francheska, Cash, Lindsay, Makris, Courtney, Lamichhane, Purushottam, Deshmukh, Rahul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047187/ https://www.ncbi.nlm.nih.gov/pubmed/32114384 http://dx.doi.org/10.1016/j.tranon.2019.12.010 |
Ejemplares similares
-
Immunotherapies and Combination Strategies for Immuno-Oncology
por: Barbari, Cody, et al.
Publicado: (2020) -
Novel Delivery Systems for Checkpoint Inhibitors
por: Lamichhane, Purushottam, et al.
Publicado: (2019) -
Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?
por: Lamichhane, Purushottam, et al.
Publicado: (2018) -
Colorectal Cancer and Probiotics: Are Bugs Really Drugs? †
por: Lamichhane, Purushottam, et al.
Publicado: (2020) -
Acquired resistance for immune checkpoint inhibitors in cancer immunotherapy: challenges and prospects
por: Chen, Xunrui, et al.
Publicado: (2022)